Terbinafine Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial Mycoses

[1]  M. Crijns,et al.  A randomized treatment duration‐finding study of terbinafine in onychomycosis , 1992, The British journal of dermatology.

[2]  M. D. Colombo,et al.  Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor , 1991, Mycoses.

[3]  T. Jones,et al.  Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. , 1991, Acta dermato-venereologica.

[4]  W. de Souza,et al.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi , 1990, Antimicrobial Agents and Chemotherapy.

[5]  D. Greer,et al.  Treatment of tinea cruris with topical terbinafine. , 1990, Journal of the American Academy of Dermatology.

[6]  L. Millikan.  Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. , 1990, Journal of the American Academy of Dermatology.

[7]  R. C. Newton,et al.  A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. , 1990, Journal of the American Academy of Dermatology.

[8]  N. Zaias,et al.  Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial. , 1990, Journal of the American Academy of Dermatology.

[9]  E. Evans,et al.  Successful treatment of chronic tinea pedis and tinea manuum with Lamisil® (terbinafine) , 1990 .

[10]  L. I. Díez,et al.  A comparative double‐blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris , 1990 .

[11]  N. Ryder.  Inhibition of squalene epoxidase and sterol side-chain methylation by allylamines. , 1990, Biochemical Society Transactions.

[12]  P. Dykes,et al.  Pharmacokinetics of topically applied terbinafine: results from studies in healthy volunteer subjects and patients with pityriasis versicolor , 1990 .

[13]  T. Jones.  Treatment of dermatomycoses with topically applied allylamines: naftifine and terbinafine , 1990 .

[14]  D. Roberts.  Current therapy for onychomycosis , 1990 .

[15]  A. Finlay,et al.  How orally administered terbinafine reaches the stratum corneum , 1990 .

[16]  T. Jones,et al.  Present status of the efficacy and tolerability of terbinafine (Lamisil) used systemically in the treatment of dermatomycoses of skin and nails , 1990 .

[17]  A. Finlay,et al.  Nail matrix kinetics of oral terbinafine in onychomycosis and normal nails , 1990 .

[18]  E. Evans,et al.  Treatment of dermatophyte infection of the finger‐ and toe‐nails with terbinafine (SF 86‐327, Lamisil), an orally active fungicidal agent , 1989, The British journal of dermatology.

[19]  J. Cutsem.  Oral, Topical and Parenteral Antifungal Treatment with Itraconazole in Normal and in Immunocompromised Animals , 1989 .

[20]  G. Cole,et al.  A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis. , 1989, Archives of dermatology.

[21]  D. Back,et al.  Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. , 1989, British journal of clinical pharmacology.

[22]  F. Schatz,et al.  Analytical methods for the determination of terbinafine and its metabolites in human plasma, milk and urine. , 1989, Arzneimittel-Forschung.

[23]  T. Jones,et al.  Clinical efficacy and tolerability of terbinafine (Lamisil)—a new topical and systemic fungicidal drug for treatment of dermatomycoses , 1989, Clinical and experimental dermatology.

[24]  H. Yamaguchi,et al.  Once daily administration of terbinafine to guinea‐pigs with experimental dermatophytosis , 1989, Clinical and experimental dermatology.

[25]  R. Savin.  Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.

[26]  D. Handley,et al.  Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo. , 1989, The Journal of pharmacology and experimental therapeutics.

[27]  G. Petrányi,et al.  Preclinical evaluation of terbinafine in vivo , 1989, Clinical and experimental dermatology.

[28]  N. Zaias,et al.  The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine , 1989, Clinical and experimental dermatology.

[29]  S. Kagawa.  Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis , 1989, Clinical and experimental dermatology.

[30]  E. Nieschlag,et al.  The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial. , 1988, Acta endocrinologica.

[31]  J. Bennett,et al.  Efficacies of four antifungal agents in experimental murine sporotrichosis , 1988, Antimicrobial Agents and Chemotherapy.

[32]  J. F. Ryley,et al.  A multi-infection model for antifungal screening in vivo. , 1988, The Journal of antimicrobial chemotherapy.

[33]  D. Armstrong,et al.  MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp , 1988, Antimicrobial Agents and Chemotherapy.

[34]  P. Regli,et al.  [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole]. , 1988, Pathologie et biologie.

[35]  G. Petrányi,et al.  Activity of terbinafine in experimental fungal infections of laboratory animals , 1987, Antimicrobial Agents and Chemotherapy.

[36]  G. Petrányi,et al.  Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.

[37]  R. Fromtling,et al.  Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells. , 1987, The Journal of antimicrobial chemotherapy.

[38]  M. Schaude,et al.  Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicans , 1987, Mykosen.

[39]  J. Berman,et al.  In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents. , 1987, The Journal of parasitology.

[40]  N. Ryder.  Mechanism of action of the allylamine antimycotics , 1987 .

[41]  A. Polak,et al.  In vitro and in vivo drug studies with three agents of central nervous system phaeohyphomycosis. , 1987, Chemotherapy.

[42]  D. Henderson,et al.  Bioassay for SF 86-327, a new antifungal agent , 1986, Antimicrobial Agents and Chemotherapy.

[43]  K. Barrett-Bee,et al.  The mode of antifungal action of tolnaftate. , 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[44]  M. Goudard,et al.  Spectre d'action in vitro d'un nouvel antifongique dérivé de la naftifine: la terbinafine (SF 86-327). , 1986 .

[45]  N S Ryder,et al.  Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes. , 1985, The Biochemical journal.

[46]  N. Ryder.  Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. , 1985, Journal of General Microbiology.

[47]  I. Schuster.  The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[48]  A. Espinel-Ingroff,et al.  In-vitro studies with SF 86-327, a new orally active allylamine derivative. , 1985, Sabouraudia.

[49]  N. Ryder.  Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent , 1985, Antimicrobial Agents and Chemotherapy.

[50]  F. Odds,et al.  Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro. , 1984, The Journal of antimicrobial chemotherapy.